Pharma Block Sciences: 300725 Yakshi Technology Investor Relations Management Information 20240425 (2)
Pharma Block Sciences: 300725 Yakshi Technology Investor Relations Management Information 20240425 (1)
Yakshi Technology: Yakishi Technology 2023 Environmental, Social and Corporate Governance (ESG) Report
Pharmaceutical Stone Technology: Opinions of Huatai United Securities Co., Ltd. on the confirmation of daily related transactions of Nanjing Yakshi Technology Co., Ltd. in 2023 and the estimated amount of daily related transactions in 2024
Yakushi Technology: Supervisory Board Resolutions Announcement
Pharmaceutical Stone Technology: Huatai United Securities Co., Ltd.'s inspection opinion on Nanjing Yakshi Technology Co., Ltd.'s 2024 external guarantee limit forecast
Yakishi Technology: Report on the work of the Supervisory Committee in 2023
Yakishi Technology: Special Report on the Deposit and Use of Funds Raised in 2023
Yakishi Technology: 2023 Annual Audit Report
Yakishi Technology: Internal Control Verification Report
Yakushi Technology: Announcement on holding the 2023 Online Results Briefing
Pharmaceutical Stone Technology: Huatai United Securities Co., Ltd.'s inspection opinions on the storage and actual use of funds raised by Nanjing Yakushi Technology Co., Ltd. in 2023
Yakshi Technology: Opinions of Huatai United Securities Co., Ltd. on the verification of the use of some temporarily idle funds raised and its own funds for cash management by Nanjing Yakushi Technology Co., Ltd.
Yakshi Technology: 2023 Independent Director Debriefing Report (Jinli)
Yakushi Technology: Announcement on applying for comprehensive credit lines from banks in 2024
Yakishi Technology: Articles of Association (April 2024)
Yakshi Technology: Huatai United Securities Co., Ltd.'s inspection opinions on Nanjing Yakshi Technology Co., Ltd.'s 2024 foreign exchange derivatives trading business
Yakishi Technology: Investor Relations Management System
Yakishi Technology: Report on the work of the Board of Directors in 2023
Yakushi Technology: Special instructions on the use of non-operating capital and other related capital transactions
No Data